600252.SH
Guangxi Wuzhou Zhongheng Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 2.18
−1.80%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 2.21
From 52W high−27.57%
Volume43.79M
Market capCNY 6.94B
P/E (TTM)−19.4x
P/S (TTM)4.4x
Div yield—
Key dataSep 18, 2026
Open
CNY 2.21
From 52W high
−27.57%
Volume
43.79M
Market cap
CNY 6.94B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−18.0x
P/E (TTM)
−19.4x
RSI (14)
44.9
MomentumView details →
1D Return
−1.80%
YTD Return
−20.44%
Similar companies
Latest newsMore news →
Wang Hairun resigned as board secretary and general counsel of Zhongheng Group, effective upon delivery to the board, while remaining a director and deputy general manager.3d agoGuangxi Guangtou Financial Holdings and its concert party Medical Health Group received a Q2 2026 continuous supervision opinion from Guohai Securities regarding their tender offer for Zhongheng Group, following Guangtou Group's September 2025 capital increase into Guangtou Financial Holdings using its 26.89% stake in Zhongheng Group.5d agoZhongheng Group's board approved extending the operating term of its consolidated partnership Guangxi Defu from June 30, 2026 to May 30, 2027, subject to partner meeting approval.34d ago